Competence Centre on Health Technologies
Follow us on

About Us

WHO WE ARE

Our Mission is to bring personalized medicine to every IFV patient. We see ourselves as an innovative research-based laboratory that contributes to patients’ well-being in partnership with IVF clinics worldwide. We value continuous research for improving the existing personalized medicine tests and finding better solutions.

Send an Email
Competence Centre on Health Technologies
(Tervisetehnoloogiate Arenduskeskus)
Teaduspargi str 13, 50411, Tartu Estonia, European Union
Call us today
+372 733 0403
Kaarel Krjutškov
Kaarel Krjutškov
PhD Head of the laboratory
Merli Saare
Merli Saare
PhD Chief specialist
Kadi Sagor
Kadi Sagor
Laboratory specialist
Neeme Tõnisson M.D.
Neeme Tõnisson M.D.
PhD Med Lab Doctor
Andres Salumets
Andres Salumets
PhD Member of Board
Priit Palta
Priit Palta
PhD Chief bioinformatician
Külli Samuel
Külli Samuel
Logistics
Signe Mölder
Signe Mölder
McS Quality manager

The beREADY team

The team consists of eminent researchers in their field – five members with a PhD and a doctor of medicine (MD). The beREADY team collaborates with several leading universities in medicine, molecular biology and genetics such as the Karolinska Institutet, Helsinki University, Leuven University, Oulu University, Granada University and others. In total, the team has published over 300 scientific articles and have applied for multiple international patents. The team members have successfully established IVF clinics and have been nominated for “Innovation of the Year” in Swedish business awards in 2016.

The Competence Centre on Health Technologies (CCHT) aims to investigate, develop and promote genetic testing assays in the filed of assisted reproductive biology as well as in all obstetrical and gynecological clinics. The laboratory also provides other advanced genetic testing services such as non-invasive prenatal genetic testing NIPT (www.niptify.ee) and preimplantation genetic screening (PGT-A). Our NIPT, branded as NIPTIFY is reimbursed by Estonia social security fund since January 2020. NIPTIFY test is a market leader NIPT in Estonia. CCHT is an approved service provider by an Estonian Health Board with a license number L05235.

Laboratory quality and approvals

beREADY technology is unique and patented. Biomarker molecules are analyzed by patented TAC-seq sequencing technology that ensures ultimate accuracy.
Laboratory has ISO 15189 certification in the filed of genomics.
Laboratory participates regulary in an independence and international EMQN quality assurance scheme.
Laboratory has Health Board permission No L05235 for molecular diagnostics.